Soleno Therapeutics, Inc. · NASDAQ:SLNO
The Vanguard Group reported a 5.28% stake in Soleno Therapeutics, Inc. (Schedule 13G)
Event Sep 30, 2025 · Filed Oct 31, 2025
The Vanguard Group reported a 5.28% stake in Soleno Therapeutics, Inc., 2,807,149 shares, as a passive investor on Sep 30, 2025. Filed Oct 31, 2025 (Schedule 13G).
- Stake
- 5.28%
- Shares
- 2,807,149
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 5.28% | 2,807,149 |
Source
Related
- Soleno Therapeutics, Inc.
- The Vanguard Group
- Soleno Therapeutics, Inc. shareholders
- Schedule 13G/A · The Vanguard Group · Mar 27, 2026
- Schedule 13G/A · Wellington Management Group LLP · Aug 13, 2026
- Form 4 · Yen Kristen · May 18, 2026
- Form 4 · Volck Birgitte · May 18, 2026
- Form 4 · Sinclair Andrew · May 18, 2026
- Form 4 · Pauls Matthew · May 18, 2026